Latest filing published 16 Sept 2024 for Inmune Bio, Inc., €89k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Raymond Joseph Tesi: trading record in brief
This profile gathers the share dealings of Raymond Joseph Tesi in Inmune Bio, Inc., where the filings describe the role as chief executive. We count 29 filings; the first trade dates from 2 May 2019 and the latest from 12 September 2024.
Market trades split into 21 purchases (€638k) and 5 sales (€1.1M). Sales outweigh purchases by €452k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants and 1 option exercise. In 2024 alone, the filings show 2 purchases and no sales.
In size, the median ticket on the buying side is €644. On 8 out of 12 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 16 September 2024 came the latest disclosure, an open-market purchase for €89k in Inmune Bio, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Raymond Joseph Tesi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,380 shares@ US$6.3754.1% of flowCommon StockSEC:0001213900-24-079121:0Canonical exit: 11 Dec 2024 (T+90)
- 18,028 shares@ US$8.326.6% of flowCommon StockSEC:0001213900-24-035722:0Canonical exit: 18 Jul 2024 (T+90)
- 18,028 shares@ US$8.326.6% of flowCommon StockSEC:0001213900-24-035474:0
- 6,300 shares@ US$6.413.1% of flowCommon StockSEC:0001213900-22-030210:0Canonical exit: 24 Aug 2022 (T+90)
- 23,724 shares@ US$8.4314.8% of flowCommon StockSEC:0001213900-22-014507:0
- 3,626 shares@ US$20.005.1% of flowCommon StockSEC:0001213900-21-056737:0
- 6,517 shares@ US$20.009.2% of flowCommon StockSEC:0001213900-21-055422:0
- 23,616 shares@ US$20.0033.2% of flowCommon StockSEC:0001213900-21-054644:0
- 30,000 shares@ US$3.918.1% of flowCommon StockSEC:0001213900-21-045373:0
- 5,649 shares@ US$20.0187.8% of flowCommon StockSEC:0001213900-21-036352:0
10 of 10 declarations